L. Goguen

发表

Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.

Laurence E Court, Megan Othus, L. Court, 2008, International journal of radiation oncology, biology, physics.

Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck.

R. Tishler, R. Haddad, L. Wirth, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

A. Sultan, R. Tishler, A. Villa, 2017, The oncologist.

Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.

R. Tishler, D. Sher, R. Haddad, 2011, International journal of radiation oncology, biology, physics.

Acupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trial.

Roger B. Davis, J. Buring, D. Rosenthal, 2012, Contemporary Clinical Trials.

Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.

P. Catalano, R. Tishler, S. Rodig, 2018, International journal of radiation oncology, biology, physics.

Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.

R. Tishler, D. Sher, R. Haddad, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

C. Paweletz, A. Egloff, R. Tishler, 2021, Clinical Cancer Research.

Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.

R. Tishler, D. Sher, R. Haddad, 2011, International journal of radiation oncology, biology, physics.

IMRT‐based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing

R. Tishler, D. Sher, N. Chau, 2019, Head & neck.

Combined antegrade and retrograde esophageal dilation for head and neck cancer‐related complete esophageal stenosis

R. Tishler, R. Haddad, M. Posner, 2010, The Laryngoscope.

Chemoradiotherapy for Adenoid Cystic Carcinoma: Preliminary Results of an Organ Sparing Approach

R. Tishler, P. Busse, R. Haddad, 2006, American journal of clinical oncology.

Efficacy and toxicity of reirradiation using intensity‐modulated radiotherapy for recurrent or second primary head and neck cancer

R. Tishler, D. Sher, A. Allen, 2010, Cancer.

Phase I study of panitumumab, chemotherapy and intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC): Early results

R. Tishler, A. Allen, R. Haddad, 2007 .

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

R. Tishler, A. Mahadevan, R. Haddad, 2004, Seminars in oncology.

Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

R. Tishler, P. Busse, A. Mahadevan, 2003, The Oncologist.

Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment

R. Tishler, R. Haddad, A. Snavely, 2013, The Laryngoscope.

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

R. Tishler, R. Haddad, L. Wirth, 2006, Archives of otolaryngology--head & neck surgery.

Organ Preservation and Treatment Toxicity With Induction Chemotherapy Followed by Radiation Therapy or Chemoradiation for Advanced Laryngeal Cancer

R. Tishler, P. Busse, R. Haddad, 2005, American journal of clinical oncology.

Dysphagia after Sequential Chemoradiation Therapy for Advanced Head and Neck Cancer

R. Tishler, R. Haddad, L. Wirth, 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.

Roger B. Davis, J. Buring, D. Rosenthal, 2016, The oncologist.

Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.

P. Catalano, R. Tishler, N. Chau, 2017, Oral oncology.

Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.

P. Catalano, R. Tishler, D. Sher, 2016, Oral oncology.

Endoscopic Management of Hypopharyngeal Stenosis after Organ Sparing Therapy for Head and Neck Cancer

R. Tishler, R. Haddad, L. Wirth, 2004, The Laryngoscope.

Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

S. Adak, R. Tishler, M. Posner, 2002, American journal of clinical oncology.

Swallowing Function following Postchemoradiotherapy Neck Dissection

R. Tishler, R. Haddad, A. Snavely, 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Docetaxel, cisplatin, and 5‐fluorouracil‐based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck

R. Tishler, P. Busse, A. Colevas, 2003, Cancer.

Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.

R. Tishler, R. Haddad, L. Wirth, 2006, Archives of otolaryngology--head & neck surgery.

The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.

R. Tishler, N. Chau, R. Haddad, 2020, The oncologist.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline

A. Sultan, R. Tishler, A. Villa, 2017, The oncologist.

Distraction osteogenesis for reconstruction of mandibular symphyseal defects.

D. Annino, L. Goguen, C. Karmody, 1994, Archives of otolaryngology--head & neck surgery.

Self-induced pneumoparotitis.

L. Goguen, B. Carter, M. April, 1995, Archives of otolaryngology--head & neck surgery.

Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy

R. Tishler, D. Sher, R. Haddad, 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.

R. Tishler, K. Wucherpfennig, S. Rodig, 2020, JAMA oncology.

Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.

R. Tishler, P. Busse, A. Mahadevan, 2006, International journal of radiation oncology, biology, physics.

Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma

P. Hammerman, R. Tishler, G. Shapiro, 2016, Clinical Cancer Research.

Successful Management of a Patient with Malignant Thyroid Teratoma.

L. Sholl, J. Barletta, J. Lorch, 2017, Thyroid : official journal of the American Thyroid Association.

Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer

P. Hammerman, R. Tishler, S. Verselis, 2017, Front. Oncol..

A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions

M. Bertagnolli, D. Dorfman, M. Othus, 2008, Cancer Prevention Research.

Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.

R. Tishler, R. Haddad, R. Uppaluri, 2022, JAMA otolaryngology-- head & neck surgery.

Accuracy and outcomes of virtual surgical planning and 3D-printed guides for osseous free flap reconstruction of mandibular osteoradionecrosis.

R. Uppaluri, Rosh K V Sethi, D. Annino, 2022, Oral oncology.

Mitomycin C for the Treatment of Pharyngoesophageal Stricture After Total Laryngopharyngectomy and Microvascular Free Tissue Reconstruction

D. Annino, L. Goguen, 2003, The Laryngoscope.

Title : Successful Management of a Patient with Malignant Thyroid Teratoma Running Title : Thyroid Teratoma with PNET Malignant Transformation

L. Sholl, J. Barletta, J. Lorch, 2016 .

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.

R. Tishler, P. Busse, A. Allen, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Pathology Quiz Case 2

V. Resto, L. Goguen, C. Lewis, 2010 .

Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers

R. Tishler, J. Killoran, R. Haddad, 2022, Head & neck.

Nasal Tuberculosis

L. Goguen, C. Karmody, 1995, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Silent sinus syndrome

D. Annino, L. Goguen, 2008, Current opinion in otolaryngology & head and neck surgery.

Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC).

D. Kallogjeri, A. Egloff, R. Paniello, 2021 .

Pain from the oral cavity.

D. Annino, L. Goguen, 2003, Otolaryngologic clinics of North America.

Neck dissection after chemoradiotherapy: timing and complications.

S. Zhao, D. Annino, L. Goguen, 2010, Archives of otolaryngology--head & neck surgery.

Representations of self across the life span.

M. Diehl, G. Labouvie-vief, L. Chiodo, 1995, Psychology and aging.

Neoadjuvant Nivolumab +/- Ipilimumab in Patients with Oral Cavity Cancer

P. Catalano, R. Tishler, N. Chau, 2020 .

Rate of complete pathological responses (pCR) to docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy in patients with newly diagnosed, locally advanced squamous cell carcinoma of the head and neck (SCCHN)

R. Tishler, R. Haddad, L. Wirth, 2005 .

Virtual planning and 3D‐printed guides for mandibular reconstruction: Factors impacting accuracy

R. Uppaluri, Rosh K V Sethi, T. Dey, 2022, Laryngoscope investigative otolaryngology.

A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC).

R. Tishler, D. Barbie, E. Marqusee, 2020 .

Assessment of Preoperative Functional Status Prior to Major Head and Neck Surgery: A Pilot Study

D. Deschler, R. Bergmark, A. Remenschneider, 2021, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).

R. Tishler, N. Chau, R. Haddad, 2018 .

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.

R. Tishler, P. Busse, A. Allen, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

C. Paweletz, D. Kallogjeri, J. Piccirillo, 2023, Science Immunology.

Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment

R. Tishler, R. Haddad, A. Snavely, 2013, The Laryngoscope.

Nivolumab for Patients With High-Risk Oral Leukoplakia

C. Paweletz, L. Alexandrov, R. Uppaluri, 2023, JAMA oncology.